CD47 checkpoint inhibitor (Biosion)

N/A

Report date: 2025/03/19 11:38:24

Base Information

Drug NameCD47 checkpoint inhibitor (Biosion)
Drug Alias Nameanti-CD47 mAb (Biosion)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionCluster of differentiation 47 inhibitors
TargetsCluster of differentiation 47
Therapy Area/IndicationsHematologic NeoplasmsMultiple Myeloma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active Companies +[1]  N/A
Inactive CompaniesN/A
Active IndicationsHematologic NeoplasmsMultiple Myeloma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A